InsiderTrades.com logo
Lisa Deschamps net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Lisa Deschamps Biography and Net Worth

Director of Verona Pharma PLC American Depositary Share
Ms Deschamps is CEO and executive board member of a private gene therapy company. Until October 2021, she was Senior Vice President, Chief Business Officer, of Novartis Gene Therapies (GTx), and previously was Head of Novartis’ Global Neuroscience Franchise. During her 25-year career at Novartis, Ms Deschamps gained significant global and US experience in bringing respiratory and other specialized therapeutic area products from the clinic to commercialization. Ms Deschamps has an MBA in General Management from NYU Stern School of Business and a BBA in marketing from IONA College, Hagan School of Business. Ms Deschamps also serves as a non-executive director and strategic advisory board member of Reset Pharmaceuticals.

What is Lisa Deschamps' net worth?

The estimated net worth of Lisa Deschamps is at least $9.07 million as of August 1st, 2025. Ms. Deschamps owns 84,856 shares of Verona Pharma PLC American Depositary Share stock worth more than $9,071,955 as of December 4th. This net worth approximation does not reflect any other investments that Ms. Deschamps may own. Learn More about Lisa Deschamps' net worth.

How do I contact Lisa Deschamps?

The corporate mailing address for Ms. Deschamps and other Verona Pharma PLC American Depositary Share executives is 3 MORE LONDON RIVERSIDE, LONDON X0, SE1 2RE. Verona Pharma PLC American Depositary Share can also be reached via phone at 011-44-0-2032834200 and via email at [email protected]. Learn More on Lisa Deschamps' contact information.

Has Lisa Deschamps been buying or selling shares of Verona Pharma PLC American Depositary Share?

Lisa Deschamps has not been actively trading shares of Verona Pharma PLC American Depositary Share over the course of the past ninety days. Most recently, Lisa Deschamps sold 9,464 shares of the business's stock in a transaction on Friday, August 1st. The shares were sold at an average price of $13.14, for a transaction totalling $124,356.96. Following the completion of the sale, the director now directly owns 84,856 shares of the company's stock, valued at $1,115,007.84. Learn More on Lisa Deschamps' trading history.

Who are Verona Pharma PLC American Depositary Share's active insiders?

Verona Pharma PLC American Depositary Share's insider roster includes Christina Ackermann (Director), Michael Austwick (Director), James Brady (Director), Kenneth Cunningham (Director), Lisa Deschamps (Director), David Ebsworth (Director), Martin Edwards (Director), Patrick Finn (Insider), Andrew Fisher (General Counsel), Mark Hahn (CFO), Claire Poll (General Counsel), Kathleen Rickard (Insider), Mahendra Shah (Director), Vikas Sinha (Director), Anders Ullman (Director), and David Zaccardelli (CEO). Learn More on Verona Pharma PLC American Depositary Share's active insiders.

Are insiders buying or selling shares of Verona Pharma PLC American Depositary Share?

In the last year, insiders at the sold shares 32 times. They sold a total of 3,057,968 shares worth more than $30,187,074.16. The most recent insider tranaction occured on August, 1st when Director Kenneth Cunningham sold 10,808 shares worth more than $142,017.12. Insiders at Verona Pharma PLC American Depositary Share own 4.8% of the company. Learn More about insider trades at Verona Pharma PLC American Depositary Share.

Information on this page was last updated on 8/1/2025.

Lisa Deschamps Insider Trading History at Verona Pharma PLC American Depositary Share

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/1/2025Sell9,464$13.14$124,356.9684,856View SEC Filing Icon  
2/1/2022Sell11,664$0.78$9,097.92View SEC Filing Icon  
11/2/2021Sell11,672$0.66$7,703.52View SEC Filing Icon  
See Full Table

Lisa Deschamps Buying and Selling Activity at Verona Pharma PLC American Depositary Share

This chart shows Lisa Deschamps's buying and selling at Verona Pharma PLC American Depositary Share by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Verona Pharma PLC American Depositary Share Company Overview

Verona Pharma PLC American Depositary Share logo
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $106.91
Low: $106.91
High: $106.91

50 Day Range

MA: $106.65
Low: $105.91
High: $106.95

2 Week Range

Now: $106.91
Low: $31.09
High: $106.93

Volume

N/A

Average Volume

1,457,608 shs

Market Capitalization

$9.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.05